Concepedia

Vesna Eraković Haber

VE

Statistics

Publications

39

Citations

1.8K

H-Index

25

Active since

1997

Affiliations

GlaxoSmithKline (Croatia)(Current)

Pliva (Croatia)

University of Zagreb

GlaxoSmithKline (United Kingdom)

GlaxoSmithKline (United States)

Vesna Eraković Haber is an author at GlaxoSmithKline (Croatia) specializing in pharmacology, inflammation, and macrolide antibiotics.

ORCID

Publications per year

1997–2021

39

Publications

39

Azithromycin modulates neutrophil function and circulating inflammatory mediators in healthy human subjects

Ognjen Čulić, Vesna Eraković Haber, Ivana Čepelak et al. · European Journal of Pharmacology · 2002 · 232 citations

, , +16

Cellular Uptake and Efflux of Azithromycin, Erythromycin, Clarithromycin, Telithromycin, and Cethromycin

Martina Bosnar, Željko Kelnerić, Vesna Munić Kos et al. · Antimicrobial Agents and Chemotherapy · 2005 · 150 citations

, , +16

Azithromycin distinctively modulates classical activation of human monocytes <i>in vitro</i>

Mila Vrančić, Mihailo Banjanac, Krunoslav Nujić et al. · British Journal of Pharmacology · 2011 · 100 citations · Full text

, , +17

Modulation of neutrophil and inflammation markers in chronic obstructive pulmonary disease by short-term azithromycin treatment

Michael J. Parnham, Ognjen Čulić, Vesna Eraković Haber et al. · European Journal of Pharmacology · 2005 · 92 citations

, , +16

Anti-inflammatory activity of azithromycin attenuates the effects of lipopolysaccharide administration in mice

Vanesa Ivetić Tkalčević, Berislav Bošnjak, Boška Hrvačić et al. · European Journal of Pharmacology · 2006 · 88 citations

, , +14

1–5 of 39